DFTX Operating Cash Flow (Statement)

Definium Therapeutics Inc · Operating Cash Flow (Statement)

DFTX logo

DFTX Operating Cash Flow (Statement)

Latest reported-$166.87M
DFTX TTM Cash from Operations (-$703.69K → -$166.87M)
High-resolution chart · PNG

DFTX operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Definium Therapeutics Inc Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
-166,867,068
-143,688,068
-130,476,068
-113,936,000
-101,560,000
-91,950,000
-79,129,000
-74,341,000
-73,776,000
-67,632,000
-64,365,000
-56,651,000
-49,322,000
-50,604,000
-50,139,000
-51,190,000
-58,675,000
-54,719,000
-51,891,000
-45,132,684
-34,154,684
-28,534,684
-23,596,692
-16,430,819
-10,895,667
-5,273,999
-334,466
-494,925
-476,611
-704,768
-719,473
-656,538
-703,685
-701,702
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.